PubMed, doi:10.1016/j.breast.2012.08.004
It seems in pre-clinical models that when these L-cells are exposed to perceived toxins, such as lipopolysaccharides from certain bacteria that this triggers a surge in endogenous GLP-1 which is perhaps the bodys way of using GLP-1 as an anti-inflammatory hormone or perhaps as a brake pedal on the inflammatory response in general
Similarly, a previous large-scale clinical trial (SUSTAIN-6) also indicated that the use of GLP-1RAs was associated with an increased risk of DR compared to the placebo group [39], but this result was based on 3,297 T2D patients from 20 countries, and 83.0% of the patients included in the trial already had cardiovascular disease or chronic kidney disease, indicating that the patient population had a high risk of complications
Taking your semaglutide injection two days early is generally safe and unlikely to cause serious harm
It is possible that we have not accounted for a term or word within our search strategy that would have retrieved additional studies and added to the depth of our scoping review
Recognizing this side effect helps in better patient counseling and preventing unnecessary discontinuation of therapy